Cargando…
High-throughput site-specific N-glycoproteomics reveals glyco-signatures for liver disease diagnosis
The glycoproteome has emerged as a prominent target for screening biomarkers, as altered glycosylation is a hallmark of cancer cells. In this work, we incorporated tandem mass tag labeling into quantitative glycoproteomics by developing a chemical labeling-assisted complementary dissociation method...
Autores principales: | Sun, Zhenyu, Fu, Bin, Wang, Guoli, Zhang, Lei, Xu, Ruofan, Zhang, Ying, Lu, Haojie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9985154/ https://www.ncbi.nlm.nih.gov/pubmed/36879659 http://dx.doi.org/10.1093/nsr/nwac059 |
Ejemplares similares
-
Fast and Comprehensive N- and O-glycoproteomics analysis with MSFragger-Glyco
por: Polasky, Daniel A., et al.
Publicado: (2020) -
Integrated GlycoProteome Analyzer (I-GPA) for Automated Identification and Quantitation of Site-Specific N-Glycosylation
por: Park, Gun Wook, et al.
Publicado: (2016) -
pGlycoQuant with a deep residual network for quantitative glycoproteomics at intact glycopeptide level
por: Kong, Siyuan, et al.
Publicado: (2022) -
Mass spectrometry-based N-glycoproteomics for cancer biomarker discovery
por: Zhang, Ying, et al.
Publicado: (2014) -
Integrative glycoproteomics reveals protein N-glycosylation aberrations and glycoproteomic network alterations in Alzheimer’s disease
por: Zhang, Qi, et al.
Publicado: (2020)